ACMG Oct 24, 2019 Genetic Testing Challenges in Oncology: Appropriate Clinical Management of BRIP1 Variant of Unknown Significance Apr 8, 2019 Cancer Sequencing Finds Germline Risk Variants in Many CHOP Pediatric Cancer Cases Apr 8, 2019 Expanded Germline Panel Testing in Cancer Patients Catches Risk Variants Missed by Focused Tests Apr 5, 2019 Color, NorthShore Pilot Project Results Reported at ACMG Apr 5, 2019 23andMe DTC Breast, Ovarian Cancer Risk Test Misses Almost 90 Percent of BRCA Mutation Carriers Dec 16, 2016 New Guidelines Aim to Standardize Interpretation and Reporting of Somatic Cancer Variants Premium Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
